Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2003
10/30/2003WO2003088981A1 Methods of treating necrotizing enterocolitis
10/30/2003WO2003088970A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003057072A3 Hemostatic compositions and methods for controlling bleeding
10/30/2003WO2003055989A3 Cellular compositions and methods of making and using them
10/30/2003WO2003051831A3 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003045404A3 Treatment and diagnosis of diseases associated with adverse levels of zinc, cadmium and calcium
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003014305A3 Eukaryotic cells and method for preserving cells
10/30/2003WO2002085340A3 Oligonucleotide compositions and their use to induce differentiation of cells
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002017711A9 Therapeutics and diagnostics based on a novel signal transduction system in platelets
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204060 Prepared by fermenting, incubating and eluting by washing with buffer, then chromatographing concentrated medium with lipophilic immobile phase comprising carrier coupled to 2-mercapto/hydroxyalkanoic acid
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203958 Therapeutic inhibitor of vascular smooth muscle cells
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203947 Activator of PPAR delta
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203891 A veterinary medicine for controlling parasites and pests on animals
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203003 Drug releasing biodegradable fiber implant
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030201160 Sterilization, neutralization of infectous viruses in blood; removal adenine, exposure to photosentizer
10/30/2003CA2483311A1 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2481786A1 Methods of treating necrotizing enterocolitis
10/30/2003CA2478991A1 Compositions and methods for augmenting kidney function
10/30/2003CA2466229A1 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/29/2003EP1357116A1 2-acylaminothiazole derivative or its salt
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355894A1 Amidinophenylalanine derivatives as thrombin inhibitors
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355674A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP0994711B1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0293394B2 Novel thrombolytic proteins
10/29/2003CN1452624A Hydropyridine deriv. acid addition salts
10/29/2003CN1452622A Piperzine devivs.
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452490A Composition and method for intervening neuronal death using sulfasalazine
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451438A Sparagin injection using xylitol as isosmotic adjusting agent
10/29/2003CN1451395A Use of silkworm excrement extract for treating iron-deficiency anemia
10/29/2003CN1125637C Application of 5,3',5'-trihydroxy-7-methoxyl dihydroflavone in preparing medicine
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638907 Laminin 8 and methods for its use
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638740 Chromatography, elution, ion exchanging
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087296A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087164A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003WO2003087161A1 Modified factor viii
10/23/2003WO2003087160A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087072A1 Therapeutic agent for endothelial disorder
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087042A1 Occlusive composition comprising a poly (2-cyanoacrylate) monomer
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 671